A pilot clinical trial with losartan in Myhre syndrome.
Gerarda CappuccioMartina CaiazzaAlessandro RocaDaniela MelisAntonella IulianoGabor MatyasMarta RubinoGiuseppe LimongelliNicola Brunetti-PierriPublished in: American journal of medical genetics. Part A (2020)
Although further long-term controlled clinical trials with a larger number of affected individuals are needed, the present study suggests that losartan might improve skin, joint and heart abnormalities of MS.